Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
- Durán, I.
- Castellano, D.
- Puente, J.
- Martín-Couce, L.
- Bello, E.
- Anido, U.
- Mas, J.M.
- Costa, L.
Aldizkaria:
Oncotarget
ISSN: 1949-2553
Argitalpen urtea: 2022
Alea: 13
Orrialdeak: 237-256
Mota: Artikulua
